Subscribe to RSS
DOI: 10.1055/s-0038-1651529
The Impact of Medical Comorbidities on Primary Total Knee Arthroplasty Reimbursements
Publication History
20 November 2017
08 April 2018
Publication Date:
23 May 2018 (online)
Abstract
Medical comorbidities have been shown to cause an increase in peri-and postoperative complications following total knee arthroplasty (TKA). However, the increase in cost associated with these complications has yet to be determined. Factors that influence cost have been of great interest particularly after the initiation of bundled payment initiatives. In this study, we present and quantify the influence of common medical comorbidities on the cost of care in patients undergoing primary TKA. A retrospective level of evidence III study was performed using the PearlDiver supercomputer to identify patients who underwent primary TKA between 2007 and 2015. Patients were stratified by medical comorbidities and compared using analysis of variance for reimbursements for the day of surgery and over 90 days postoperatively. A cohort of 137,073 US patients was identified as having undergone primary TKA between 2007 and 2015. The mean entire episode-of-care reimbursement was $23,701 (range: $21,294–26,299; standard deviation [SD] $2,611). The highest reimbursements were seen in patients with chronic obstructive pulmonary disease (mean $26,299; SD $3,030), hepatitis C (mean $25,662; SD $2,766), morbid obesity (mean $25,450; SD $2,154), chronic kidney disease (mean $25,131, $3,361), and cirrhosis (mean $24,890; SD $2,547). Medical comorbidities significantly impact reimbursements, and therefore cost, after primary TKA. Comprehensive preoperative optimization for patients with medical comorbidities undergoing TKA is highly recommended and may reduce perioperative complications, improve patient outcome, and ultimately reduce cost.
-
References
- 1 Ponnusamy KE, Jain A, Thakkar SC, Sterling RS, Skolasky RL, Khanuja HS. Inpatient mortality and morbidity for dialysis-dependent patients undergoing primary total hip or knee arthroplasty. J Bone Joint Surg Am 2015; 97 (16) 1326-1332
- 2 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
- 3 Losina E, Walensky RP, Kessler CL. , et al; Patient Risk and Hospital Volume. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med 2009; 169 (12) 1113-1121
- 4 Kurtz SM, Ong KL, Schmier J. , et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007; 89 (Suppl. 03) 144-151
- 5 Nichols CI, Vose JG. Clinical outcomes and costs within 90 days of primary or revision total joint arthroplasty. J Arthroplasty 2016; 31 (07) 1400-1406
- 6 Pugely AJ, Martin CT, Gao Y, Belatti DA, Callaghan JJ. Comorbidities in patients undergoing total knee arthroplasty: do they influence hospital costs and length of stay?. Clin Orthop Relat Res 2014; 472 (12) 3943-3950
- 7 Belatti DA, Pugely AJ, Phisitkul P, Amendola A, Callaghan JJ. Total joint arthroplasty: trends in Medicare reimbursement and implant prices. J Arthroplasty 2014; 29 (08) 1539-1544
- 8 Rosas S, Sabeh KG, Buller LT, Law TY, Roche MW, Hernandez VH. Medical comorbidities impact the episode-of-care reimbursements of total hip arthroplasty. J Arthroplasty 2017; 32 (07) 2082-2087
- 9 Alluri RK, Leland H, Heckmann N. Surgical research using national databases. Ann Transl Med 2016; 4 (20) 393
- 10 Bjorgul K, Novicoff WM, Saleh KJ. Evaluating comorbidities in total hip and knee arthroplasty: available instruments. J Orthop Traumatol 2010; 11 (04) 203-209
- 11 Hogan CA, Sandoval MF, Uhler LM. Centers for Medicare & Medicaid Services' Comprehensive Care for Joint Replacement: the present and future for orthopedic surgeons. Orthopedics 2017; 40 (02) 77-80
- 12 Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005; 87 (08) 1746-1751
- 13 Cary Jr MP, Baernholdt M, Merwin EI. Changes in payment regulation and acute care use for total hip replacement: trends in length of stay, costs, and discharge, 1997–2012. Rehabil Nurs 2016; 41 (02) 67-77
- 14 González-Vélez AE, Romero-Martín M, Villanueva-Orbaiz R, Díaz-Agero-Pérez C, Robustillo-Rodela A, Monge-Jodra V. The cost of infection in hip arthroplasty: a matched case-control study [Article in Spanish]. Rev Esp Cir Ortop Traumatol 2016; 60 (04) 227-233
- 15 Gutowski CJ, Zmistowski BM, Lonner JH, Purtill JJ, Parvizi J. Direct costs of aspirin versus warfarin for venous thromboembolism prophylaxis after total knee or hip arthroplasty. J Arthroplasty 2015; 30 (9, Suppl): 36-38
- 16 Kiridly DN, Karkenny AJ, Hutzler LH, Slover JD, Iorio R, Bosco III JA. The effect of severity of disease on cost burden of 30-day readmissions following total joint arthroplasty (TJA). J Arthroplasty 2014; 29 (08) 1545-1547
- 17 Scott CE, Howie CR, MacDonald D, Biant LC. Predicting dissatisfaction following total knee replacement: a prospective study of 1217 patients. J Bone Joint Surg Br 2010; 92 (09) 1253-1258
- 18 Sabeh KG, Rosas S, Buller LT, Roche MW, Hernandez VH. The impact of discharge disposition on episode-of-care reimbursement after primary total hip arthroplasty. J Arthroplasty 2017; 32 (10) 2969-2973
- 19 Newman JM, Szubski CR, Barsoum WK, Higuera CA, Molloy RM, Murray TG. Day of surgery affects length of stay and charges in primary total hip and knee arthroplasty. J Arthroplasty 2017; 32 (01) 11-15
- 20 Wasielewski RC, Weed H, Prezioso C, Nicholson C, Puri RD. Patient comorbidity: relationship to outcomes of total knee arthroplasty. Clin Orthop Relat Res 1998; (356) 85-92
- 21 Clement ND. Patient factors that influence the outcome of total knee replacement: a critical review of the literature. OA Orthopaedics 2013; 1: 11
- 22 Scott CE, Bugler KE, Clement ND, MacDonald D, Howie CR, Biant LC. Patient expectations of arthroplasty of the hip and knee. J Bone Joint Surg Br 2012; 94 (07) 974-981
- 23 Newman JM, Schiltz NK, Mudd CD, Szubski CR, Klika AK, Barsoum WK. Impact of cirrhosis on resource use and inpatient complications in patients undergoing total knee and hip arthroplasty. J Arthroplasty 2016; 31 (11) 2395-2401
- 24 Best MJ, Buller LT, Klika AK, Barsoum WK. Increase in perioperative complications following primary total hip and knee arthroplasty in patients with hepatitis C without cirrhosis. J Arthroplasty 2015; 30 (04) 663-668
- 25 Pour AE, Matar WY, Jafari SM, Purtill JJ, Austin MS, Parvizi J. Total joint arthroplasty in patients with hepatitis C. J Bone Joint Surg Am 2011; 93 (15) 1448-1454
- 26 Deleuran T, Vilstrup H, Overgaard S, Jepsen P. Cirrhosis patients have increased risk of complications after hip or knee arthroplasty. Acta Orthop 2015; 86 (01) 108-113
- 27 Salih S, Sutton P. Obesity, knee osteoarthritis and knee arthroplasty: a review. BMC Sports Sci Med Rehabil 2013; 5 (01) 25
- 28 Cho HJ, Morey V, Kang JY, Kim KW, Kim TK. Prevalence and risk factors of spine, shoulder, hand, hip, and knee osteoarthritis in community-dwelling Koreans older than age 65 years. Clin Orthop Relat Res 2015; 473 (10) 3307-3314
- 29 Ackerman IN, Osborne RH. Obesity and increased burden of hip and knee joint disease in Australia: results from a national survey. BMC Musculoskelet Disord 2012; 13: 254
- 30 Workgroup of the American Association of Hip and Knee Surgeons Evidence Based Committee. Obesity and total joint arthroplasty: a literature based review. J Arthroplasty 2013; 28 (05) 714-721
- 31 Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty 2009; 24 (6, Suppl): 84-88
- 32 Jibodh SR, Gurkan I, Wenz JF. In-hospital outcome and resource use in hip arthroplasty: influence of body mass. Orthopedics 2004; 27 (06) 594-601
- 33 Macario A. What does one minute of operating room time cost?. J Clin Anesth 2010; 22 (04) 233-236
- 34 Kakar PN, Roy PM, Pant V, Das J. Anesthesia for joint replacement surgery: issues with coexisting diseases. J Anaesthesiol Clin Pharmacol 2011; 27 (03) 315-322
- 35 Liao KM, Lu HY. Complications after total knee replacement in patients with chronic obstructive pulmonary disease: a nationwide case-control study. Medicine (Baltimore) 2016; 95 (37) e4835
- 36 Bozic KJ, Lau E, Ong K. , et al. Risk factors for early revision after primary TKA in Medicare patients. Clin Orthop Relat Res 2014; 472 (01) 232-237
- 37 Courtney PM, Melnic CM, Gutsche J, Hume EL, Lee GC. Which patients need critical care intervention after total joint arthroplasty? A prospective study of factors associated with the need for intensive care following surgery. Bone Joint J 2015; 97-B (11) 1512-1518
- 38 Courtney PM, Rozell JC, Melnic CM, Lee GC. Who should not undergo short stay hip and knee arthroplasty? Risk factors associated with major medical complications following primary total joint arthroplasty. J Arthroplasty 2015; 30 (9, Suppl): 1-4
- 39 Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006; 28 (02) 346-351
- 40 Sullivan R, Jarvis LD, O'Gara T, Langfitt M, Emory C. Bundled payments in total joint arthroplasty and spine surgery. Curr Rev Musculoskelet Med 2017; 10 (02) 218-223